Panelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH ...
CAR T-cell therapies are individualized treatments approved for multiple hematologic malignancies, with improved management of adverse effects over time. Access to CAR T-cell therapies is limited by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback